What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?

Osteonecrosis of the jaw represents interference by external and internal factors in the natural bone remodeling system. Numerous bone remodeling agents (BMAs), such as bisphosphonates, denosumab, and tyrosine kinase inhibitors, can lead to medication-related osteonecrosis of the jaw (MRONJ). This i...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Mihai Vlad Golu, Ionela Pașcanu, Cornelia Togănel, Cecilia Petrovan, Adina Cosarcă, Despina Luciana Bereczki Temistocle, Alina Ormenișan
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2022-09-01
סדרה:	Applied Sciences
נושאים:	osteonecrosis of the jaw medication-related osteonecrosis of the jaw bisphosphonate-related osteonecrosis of the jaw dentistry oral health multidisciplinary approach
גישה מקוונת:	https://www.mdpi.com/2076-3417/12/18/9224
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!